62 related articles for article (PubMed ID: 16472703)
1. Second-line treatment options in advanced non-small cell lung cancer: current status.
Cullen M
Semin Oncol; 2006 Feb; 33(1 Suppl 1):S3-8. PubMed ID: 16472703
[TBL] [Abstract][Full Text] [Related]
2. Use of novel second-line targeted therapies in non-small cell lung cancer.
Massarelli E; Herbst RS
Semin Oncol; 2006 Feb; 33(1 Suppl 1):S9-16. PubMed ID: 16472704
[TBL] [Abstract][Full Text] [Related]
3. Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC).
Reck M
Anticancer Res; 2005; 25(3A):1501-6. PubMed ID: 16033051
[TBL] [Abstract][Full Text] [Related]
4. Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?
Galetta D; Rossi A; Colucci G; Gebbia V
Oncology; 2009; 77 Suppl 1():113-21. PubMed ID: 20130439
[TBL] [Abstract][Full Text] [Related]
5. Optimizing therapy in previously treated non-small cell lung cancer.
Miller VA
Semin Oncol; 2006 Feb; 33(1 Suppl 1):S25-31. PubMed ID: 16472706
[TBL] [Abstract][Full Text] [Related]
6. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
Maione P; Gridelli C; Troiani T; Ciardiello F
Oncologist; 2006 Mar; 11(3):274-84. PubMed ID: 16549812
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():37-46. PubMed ID: 18263773
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
[TBL] [Abstract][Full Text] [Related]
9. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
Quoix E
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
[TBL] [Abstract][Full Text] [Related]
10. New antiangiogenetic agents and non-small cell lung cancer.
Gridelli C; Rossi A; Maione P
Crit Rev Oncol Hematol; 2006 Oct; 60(1):76-86. PubMed ID: 16843002
[TBL] [Abstract][Full Text] [Related]
11. Second and third line treatment in non-small cell lung cancer.
Favaretto A; Pasello G; Magro C; Schettino C; Gridelli C
Crit Rev Oncol Hematol; 2009 Aug; 71(2):117-26. PubMed ID: 19249227
[TBL] [Abstract][Full Text] [Related]
12. Improving patient management in metastatic non-small cell lung cancer.
Vansteenkiste J
Lung Cancer; 2007 Aug; 57 Suppl 2():S12-7. PubMed ID: 17686440
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
[TBL] [Abstract][Full Text] [Related]
14. Geographic variation in the second-line treatment of non-small cell lung cancer.
Edelman MJ; Sekine I; Tamura T; Saijo N
Semin Oncol; 2006 Feb; 33(1 Suppl 1):S39-44. PubMed ID: 16472708
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
[TBL] [Abstract][Full Text] [Related]
16. The need for third-line treatment in non-small cell lung cancer: an overview of new options.
Syrigos KN; Saif MW; Karapanagiotou EM; Oikonomopoulos G; De Marinis F
Anticancer Res; 2011 Feb; 31(2):649-59. PubMed ID: 21378351
[TBL] [Abstract][Full Text] [Related]
17. [Advance of second-line chemotherapy in advanced non-small cell lung cancer.].
Zhang L
Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):4-9. PubMed ID: 20727256
[TBL] [Abstract][Full Text] [Related]
18. Second- and third-line treatments in non-small cell lung cancer.
Kumar A; Wakelee H
Curr Treat Options Oncol; 2006 Jan; 7(1):37-49. PubMed ID: 16343367
[TBL] [Abstract][Full Text] [Related]
19. Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
Gebbia V
Expert Opin Pharmacother; 2008 Jun; 9(8):1321-37. PubMed ID: 18473707
[TBL] [Abstract][Full Text] [Related]
20. Second-line Therapy for advanced non-small-cell lung cancer.
Hann CL; Brahmer JR
Curr Oncol Rep; 2006 Jul; 8(4):243-7. PubMed ID: 17254522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
